Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to determine the effects of a low Fermentescible Oligosaccharides Disaccharides Monosaccharides and Polyols (FODMAP) diet in patients with documented refractory GERD on proton pump inhibitor (PPI) therapy.


Clinical Trial Description

Colonic fermentation has been shown to influence oeso-gastric motility : increased gastric relaxation, increased rate of lower esophageal sphincter relaxation. Experimental increased colonic fermentation (FOS in diet) increase the occurrence of reflux events in patients with GERD. The aim of this study is to compare the low-FODMAP diet and classical GERD dietary recommendations (avoid fatty meals, head of bed elevation etc..) in patients with refractory GERD symptoms. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02471989
Study type Interventional
Source University Hospital, Bordeaux
Contact Frank ZERBIB, Prof
Phone (0)556795806
Email frank.zerbib@chu-bordeaux.fr
Status Recruiting
Phase N/A
Start date November 2015
Completion date December 2017

See also
  Status Clinical Trial Phase
Withdrawn NCT02812407 - HRIM vs Mucosal Impedance in GERD Participants N/A
Completed NCT02623062 - Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study Phase 3
Terminated NCT02619747 - Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients Phase 3